awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38664981-A52B5000-3461-4636-A090-E4832DB6341B
Q38664981-A52B5000-3461-4636-A090-E4832DB6341B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38664981-A52B5000-3461-4636-A090-E4832DB6341B
Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry.
P2860
Q38664981-A52B5000-3461-4636-A090-E4832DB6341B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38664981-A52B5000-3461-4636-A090-E4832DB6341B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0543a459da4b2ae1fdd32ac7eb2d9b3a7013c99a
P2860
Rituximab use in everyday clinical practice as a first-line biologic therapy for the treatment of DMARD-resistant rheumatoid arthritis.